Published in Br J Haematol on October 01, 1989
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc (2009) 1.88
Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy. Br J Cancer (1995) 0.94
Waldenström's macroglobulinaemia secreting a paraprotein with lupus anticoagulant activity: possible association with gastrointestinal tract disease and malabsorption. J Clin Pathol (1993) 0.80
Multiple myeloma presenting as mesenteric venous thrombosis and intestinal infarction. Dig Dis Sci (2005) 0.79
Interference of M-protein on prothrombin time test - case report. Biochem Med (Zagreb) (2016) 0.75
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature (1993) 7.89
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci (2000) 1.83
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia (2011) 1.70
Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.69
Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity. Nucleic Acids Res (1993) 1.62
Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A (1995) 1.61
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia (2012) 1.60
A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol (1988) 1.58
[Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment]. Rev Invest Clin (2000) 1.52
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49
Platelet function after in vivo and in vitro treatment with thrombolytic agents. Am J Cardiol (1992) 1.49
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. Minerva Anestesiol (2011) 1.41
Neuropathies associated with monoclonal gammapathies. Haematologica (1995) 1.40
["La Revista de Investigación Clínica" facing new challenges and old conflicts]. Rev Invest Clin (2000) 1.39
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica (1999) 1.38
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. Acta Neurol Scand (2009) 1.38
Functional comparison of the K+-Cl- cotransporters KCC1 and KCC4. J Biol Chem (2000) 1.38
[Thrombosis, antibodies, and systemic lupus erythematosus]. Rev Invest Clin (2000) 1.37
Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability. J Struct Biol (2000) 1.31
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27
Breast cancer in young women: clinicopathological features and biological specificity. Breast (2003) 1.25
Changing clinical presentation of multiple myeloma. Eur J Cancer (1991) 1.24
Beta2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils. Eur J Biochem (1998) 1.23
Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family. J Biol Chem (1999) 1.23
The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A (2000) 1.20
Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: a new model for ions and diuretics interaction. Am J Physiol Renal Physiol (2000) 1.20
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem (2001) 1.19
Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17
Serum albumin in Hodgkin's disease. Cancer (1985) 1.17
Intranuclear cisternae resembling structures of the Golgi complex. J Cell Biol (1966) 1.15
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09
Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. Br J Haematol (2001) 1.08
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica (2000) 1.08
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol (1999) 1.07
The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer (1990) 1.07
C-type particles in primary and transplanted lung tumors induced in BALB-c mice by hydrazine sulfate: electron microscopic and immunodiffusion studies. J Natl Cancer Inst (1972) 1.06
Ultrastructure of meningeal tumors induced in dogs with Rous sarcoma virus. J Natl Cancer Inst (1967) 1.04
Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol (1999) 1.01
Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol (1986) 1.01
Drosophila male meiosis as a model system for the study of cytokinesis in animal cells. Cell Struct Funct (2001) 1.01
Primary splenic lymphoma: does it exist? Haematologica (1994) 1.00
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
Identification, retinoid binding, and x-ray analysis of a human retinol-binding protein. Proc Natl Acad Sci U S A (2001) 1.00
Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes. Haemostasis (1974) 1.00
Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med (1995) 1.00
Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis. Br J Haematol (1996) 0.98
Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol (2001) 0.98
Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol (1998) 0.97
The molecular defect of albumin Tagliacozzo: 313 Lys----Asn. FEBS Lett (1986) 0.97
Structural characterization of two genetic variants of human serum albumin. Biochim Biophys Acta (1987) 0.97
Giant cell tumor of tendon sheath: immunohistochemical study of 20 cases. Tumori (1998) 0.97
Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology. Clin Exp Rheumatol (2006) 0.97
Biological activity and pathological implications of misfolded proteins. Cell Mol Life Sci (1999) 0.97
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res Treat (2003) 0.96
The coronary subclavian steal syndrome: an uncommon sequel to internal mammary-coronary artery bypass surgery. Thorac Cardiovasc Surg (1994) 0.96
Limited proteolysis of chloroplast glyceraldehyde-3-phosphate dehydrogenase (NADP) from Spinacia oleracea. Biol Chem Hoppe Seyler (1993) 0.96
Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol (1990) 0.95
The reliability of leg circumference assessment: a comparison of spring tape measurements and optoelectronic volumetry. Vasc Med (2000) 0.95
Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer (1983) 0.95
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol (1990) 0.95
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood (1994) 0.95
Ultrastructure of gliomas induced in hamsters with Rous sarcoma virus. J Natl Cancer Inst (1967) 0.95
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. Br J Haematol (2001) 0.95
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils. Eur J Biochem (1997) 0.95
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94
Ciliated cyst of the perineal skin. Am J Dermatopathol (1997) 0.94
Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93
Functional and molecular characterization of the K-Cl cotransporter of Xenopus laevis oocytes. Am J Physiol Cell Physiol (2001) 0.93
Hodgkin's disease prognosis: a directly predictive equation. Lancet (1988) 0.93
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res (1988) 0.93
Isoforms of the Na-K-2Cl cotransporter in murine TAL II. Functional characterization and activation by cAMP. Am J Physiol (1999) 0.93
An IgM monoclonal protein with multiple serological specificities. Clin Exp Immunol (1979) 0.93
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol (2004) 0.93
Interactions with retinol and retinoids of bovine cellular retinol-binding protein. Eur J Biochem (1995) 0.92
A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood (1980) 0.92
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. Am J Hematol (1994) 0.92
Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol (1976) 0.92
Biological prognostic factors for early stage completely resected non-small cell lung cancer. J Surg Oncol (2000) 0.92
New drug therapy of amyloidoses: resorption of AL-type deposits with 4'-iodo-4'-deoxydoxorubicin. Blood (1995) 0.92
Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol (2010) 0.91
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? Rheumatology (Oxford) (2005) 0.91
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects. QJM (2011) 0.90
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. Histopathology (1997) 0.90